Difference between revisions of "Eluvixtamab (AMG-330)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Warner-admin moved page Eluvixtamab (AMG 330) to Eluvixtamab (AMG-330) without leaving a redirect) |
Warner-admin (talk | contribs) m (Text replacement - "BiTE antibodies" to "bispecific T-cell engager antibodies") |
||
| Line 10: | Line 10: | ||
[[Category:T-cell activators]] | [[Category:T-cell activators]] | ||
| − | [[Category:Anti-CD33 | + | [[Category:Anti-CD33 bispecific T-cell engager antibodies]] |
| − | [[Category:Anti-CD3 | + | [[Category:Anti-CD3 bispecific T-cell engager antibodies]] |
[[Category:Investigational drugs]] | [[Category:Investigational drugs]] | ||
Revision as of 13:06, 23 September 2023
Mechanism of action
Bispecific T-cell engager (BiTE) antibody that engages CD33 and CD3
Also known as
- Code name: AMG-330